A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations

BACKGROUND: The incidence of lung adenocarcinoma (LUAD) is increasing worldwide with different prognosis even in early-stage patients. We aimed to identify a prognostic panel with multiple DNA methylation biomarkers to predict survival in early-stage LUAD patients of different racial groups. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, I-Ying, Jen, Jayu, Hsu, Lien-Huei, Hsu, Han-Shui, Lai, Wu-Wei, Wang, Yi-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969679/
https://www.ncbi.nlm.nih.gov/pubmed/27484806
http://dx.doi.org/10.1186/s12929-016-0276-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969679/
https://www.ncbi.nlm.nih.gov/pubmed/27484806
http://dx.doi.org/10.1186/s12929-016-0276-x

Ejemplares similares